Efficacy and Safety of Beta-glucan Supplement in Chronic Obstructive Pulmonary Disease Patients
NCT ID: NCT05878834
Last Updated: 2023-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
72 participants
INTERVENTIONAL
2023-05-25
2023-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Muscle Exercise Training in COPD Patients
NCT01747694
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
NCT01739790
Oral β-Alanine Supplementation in Patients With COPD
NCT02770417
AECOPD and Nutritional Supplementation in COPD
NCT06801964
Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation
NCT03643302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beta-glucan supplement group
Beta-glucan supplement capsule composes of beta-glucan 250 mg, broccoli 75 mg, quercetin 50 mg.
Beta-glucan supplement group
Take 1 capsule 1 time per day for 12 weeks.
Placebo group
Placebo capsule is empty capsule.
Placebo group
Take 1 capsule 1 time per day for 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beta-glucan supplement group
Take 1 capsule 1 time per day for 12 weeks.
Placebo group
Take 1 capsule 1 time per day for 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic Obstructive Pulmonary Disease with Forced expiratory volume in 1 second/Forced vital capacity after receiving bronchodilator medicine more than 70%
* No exacerbation and uncontrolled disease
* 10 pack-years smoking history 10 pack-years but stop smoking more than 1 years
* Willing to participate in this study
Exclusion Criteria
* Lung cancer
* Liver disease or kidney disease
* Lung surgery history
* Take kung supplement in 2 weeks
* Take warfarin, clopidogrel, aspirin, or digoxin
* Allergic to beta-glucan, broccoli, or quercetin
* Cannot use Spirometry
* Pregnancy and lactation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pornanong Aramwit, Pharm.D., Ph.D
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pornanong Aramwit, Professor
Role: PRINCIPAL_INVESTIGATOR
Chulalongkorn University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Oh87/65
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.